A Complete Guide for International Patients Seeking Medical Treatment in China: From Medical Record Evaluation to Hospital Admission

In recent years, with the rapid development of China’s medical technology, the continuous launch of innovative drugs, and the steady improvement of its international healthcare service system, more and more overseas patients have chosen to travel to China for treatment. Especially in areas such as cancer treatment, CAR-T cell therapy, precision medicine, minimally invasive intervention, and complex diseases, China is gradually becoming an important destination for global cross-border healthcare.

For many international patients, one of the biggest concerns is: What is the medical treatment process for overseas patients in China? Is it complicated to seek treatment in China? How can patients book hospitals and complete medical record evaluations?

In fact, as China’s international medical services continue to mature, the process for overseas patients seeking treatment in China has become increasingly standardized. From remote medical record evaluations and hospital appointments to visa assistance, inpatient treatment, and post-treatment rehabilitation management, China has established a relatively comprehensive international patient service system. Dengyue will provide a detailed overview of the entire process for overseas patients seeking treatment in China, helping patients better understand how China’s healthcare system works.

Why Are More International Patients Choosing China for Treatment?

In the past, many international patients preferred to seek advanced medical treatment in countries such as the United States, Japan, and Germany. However, in recent years, China’s healthcare system has been attracting more overseas patients due to several advantages:

●  Rapid advancement in cancer treatment technologies

●  Improved accessibility to innovative drugs

●  Fast development of CAR-T cell therapy

●  More cost-effective treatment options

●  Shorter waiting times for medical care

●  Continuous improvement of international patient services

Particularly in the treatment of lung cancer, breast cancer, liver cancer, lymphoma, and other cancers, many large Chinese hospitals have already reached internationally advanced standards.

At the same time, regions such as Guangzhou, Shanghai, Beijing, and the Guangdong-Hong Kong-Macao Greater Bay Area are accelerating the development of international medical centers, further improving the convenience of overseas patients traveling to China for treatment.

Step 1: Remote Medical Record Evaluation Is the Starting Point

For overseas patients, treatment in China usually begins with a remote medical record evaluation. Patients are generally required to prepare the following documents in advance:

●  Pathology reports

●  CT/MRI/PET-CT imaging results

●  Genetic testing reports

●  Previous treatment records

●  Current medication information

●  Blood test results

Chinese medical experts will conduct a preliminary analysis of the patient’s condition, evaluate whether treatment in China is suitable, and provide initial treatment recommendations.

For cancer patients in particular, medical record evaluation is extremely important. Through this process, patients can better understand:

●  Whether there are new treatment opportunities

●  Whether CAR-T therapy is suitable

●  Whether targeted therapy or immunotherapy is appropriate

●  Whether innovative drugs are available

●  Whether surgery or combined treatment is necessary

Dengyue Pharma helps international patients connect with high-quality Chinese cancer hospitals, innovative treatment resources, and cross-border medical service systems. The company assists patients with medical record evaluations, specialist appointments, and treatment coordination in China, further improving the efficiency of overseas patient care.

Step 2: Hospital Appointments and Specialist Consultations

After completing the medical record evaluation, patients can move on to the hospital appointment stage.

Currently, many major Chinese hospitals have established international patient green channels that help overseas patients quickly complete:

●  Specialist appointments

●  MDT (Multidisciplinary Team) consultations

●  Examination scheduling

●  Hospital admission coordination

●  Personalized treatment planning

In comprehensive cancer treatment, MDT consultations have become a key diagnostic and treatment model in major Chinese cancer hospitals. Through joint discussions among oncology surgeons, radiologists, pathologists, imaging specialists, and immunotherapy teams, patients can receive more precise treatment plans.

In recent years, Guangzhou Royal Lee Cancer Hospital has continuously improved its international patient service system. The hospital has attracted more overseas patients seeking consultation and treatment in areas such as minimally invasive oncology treatment, precision medicine, and international patient coordination services.

For many international patients, one of the major advantages of China’s healthcare system is efficiency. Compared with waiting periods of several weeks or even months in some countries, many Chinese hospitals can arrange specialist consultations and treatment plans much more quickly.

Step 3: Visa Applications and Travel Arrangements

After confirming the treatment plan, overseas patients usually begin preparing for their trip to China.

Currently, China has gradually improved various convenience measures for international medical needs, including:

●  Medical visa support

●  International patient invitation letters

●  Hospital appointment certificates

●  Medical translation services

●  Airport pickup and accommodation assistance

Some cross-border medical service providers can also assist patients with:

●  Medical interpreters

●  Airport transportation

●  Patient companion services

●  Hotel bookings

●  Daily life coordination during treatment

For cancer patients, treatment cycles may be relatively long, making advance travel planning especially important.

This is particularly true for treatments such as:

●  CAR-T cell therapy

●  Radiotherapy

●  Immunotherapy

●  Cancer surgery

●  Cell therapy

Patients usually need to arrange treatment schedules and postoperative recovery periods in advance.

Step 4: Hospital Admission and Formal Treatment

After arriving in China, patients usually undergo further examinations.

These may include:

●  Pathology review

●  Blood tests

●  Imaging re-examinations

●  Additional genetic testing

●  Physical function assessments

These examinations help doctors further confirm the patient’s condition and finalize the treatment plan.

Currently, cancer treatment in China is becoming increasingly comprehensive. Many patients no longer receive only a single form of treatment, but rather a combination of:

●  Surgery

●  Radiotherapy

●  Targeted therapy

●  Immunotherapy

●  Minimally invasive intervention

●  CAR-T cell therapy

In particular, China has seen extremely rapid development in precision medicine in recent years. Innovative therapies such as:

●  ADC drugs

●  Bispecific antibodies

●  PD-1/PD-L1 immunotherapy

●  CAR-T cell therapy

●  Gene and cell therapy

are bringing new treatment opportunities to more patients with advanced cancers.

Step 5: Post-Treatment Follow-Up and Long-Term Management

For overseas patients, receiving treatment in China does not mean “leaving immediately after treatment ends.”

Currently, many Chinese international medical centers have established remote follow-up systems that allow patients to continue receiving care after returning home, including:

●  Remote follow-up consultations

●  Medication guidance

●  Imaging review analysis

●  Rehabilitation management

●  Long-term disease monitoring

This cross-border long-term management model has further improved the treatment experience for overseas patients.

For cancer patients especially, long-term follow-up is important for:

●  Monitoring recurrence

●  Adjusting medications

●  Managing side effects

●  Improving quality of life

China’s International Medical Services Continue to Improve

In recent years, China has continued to expand the openness of its international healthcare system.

Particularly in the Guangdong-Hong Kong-Macao Greater Bay Area and the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, international healthcare infrastructure is rapidly developing.

This includes:

●  Direct settlement with international commercial insurance

●  Hong Kong and Macao drug and medical device access policies

●  International remote consultations

●  Green channels for international patients

●  Multilingual medical services

All of these measures are improving the convenience of overseas patients seeking treatment in China.

As precision medicine, innovative drugs, and international medical cooperation continue to deepen, China is gradually building a complete international healthcare competitive advantage.

Conclusion: Seeking Treatment in China Is Becoming a New Choice for More International Patients

From medical record evaluations and specialist appointments to treatment coordination and formal therapy, China’s international medical service system is becoming increasingly mature.

For overseas patients, China is no longer simply a “lower-cost alternative,” but is increasingly becoming an important medical destination that combines:

●  Strong medical technology

●  High treatment efficiency

●  Innovation capabilities

●  Cost-effectiveness

●  International patient service experience

In the future, as China continues to develop precision medicine, cell therapy, and innovative drugs, the demand for overseas patients seeking treatment in China is expected to continue growing.

For international patients who wish to learn more about Chinese cancer hospitals, CAR-T therapy, innovative drugs, and treatment procedures in China, Dengyue Pharma is also helping patients connect with high-quality Chinese medical resources such as Guangzhou Royal Lee Cancer Hospital, assisting patients in completing medical record evaluations, hospital appointments, and cross-border medical coordination services more efficiently.